Pure Biologics Financial Leverage

Financial Leverage (Equity Multiplier) of Pure Biologics is -0.18 in 2026.

Financial Leverage (Equity Multiplier) of Pure Biologics changed from 12.01 to -0.18, representing a -101.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Pure Biologics with sector peers and the industry average to assess whether it is attractive.